The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples